PL2820010T3 - Pochodne benzofurano-2-sulfonamidu jako modulatory receptora chemokinowego - Google Patents
Pochodne benzofurano-2-sulfonamidu jako modulatory receptora chemokinowegoInfo
- Publication number
- PL2820010T3 PL2820010T3 PL13711995T PL13711995T PL2820010T3 PL 2820010 T3 PL2820010 T3 PL 2820010T3 PL 13711995 T PL13711995 T PL 13711995T PL 13711995 T PL13711995 T PL 13711995T PL 2820010 T3 PL2820010 T3 PL 2820010T3
- Authority
- PL
- Poland
- Prior art keywords
- benzofuran
- chemokine receptor
- receptor modulators
- sulfonamide derivatives
- sulfonamide
- Prior art date
Links
- PBECZJTWMSIKFE-UHFFFAOYSA-N 1-benzofuran-2-sulfonamide Chemical class C1=CC=C2OC(S(=O)(=O)N)=CC2=C1 PBECZJTWMSIKFE-UHFFFAOYSA-N 0.000 title 1
- 102000009410 Chemokine receptor Human genes 0.000 title 1
- 108050000299 Chemokine receptor Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261605300P | 2012-03-01 | 2012-03-01 | |
| EP13711995.4A EP2820010B1 (en) | 2012-03-01 | 2013-03-01 | Benzofuran-2-sulfonamide derivatives as chemokine receptor modulators |
| PCT/US2013/028607 WO2013130962A1 (en) | 2012-03-01 | 2013-03-01 | Benzofuran- 2 - sulfonamide derivatives as chemokine receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2820010T3 true PL2820010T3 (pl) | 2018-11-30 |
Family
ID=47902352
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18156011T PL3345899T3 (pl) | 2012-03-01 | 2013-03-01 | Pochodne benzofurano-2-sulfonoamidu jako modulatory receptorów chemokin |
| PL13711995T PL2820010T3 (pl) | 2012-03-01 | 2013-03-01 | Pochodne benzofurano-2-sulfonamidu jako modulatory receptora chemokinowego |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18156011T PL3345899T3 (pl) | 2012-03-01 | 2013-03-01 | Pochodne benzofurano-2-sulfonoamidu jako modulatory receptorów chemokin |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US8815915B2 (pl) |
| EP (2) | EP3345899B1 (pl) |
| AU (2) | AU2013225815B2 (pl) |
| CA (1) | CA2866078C (pl) |
| CY (1) | CY1120528T1 (pl) |
| DK (2) | DK3345899T3 (pl) |
| ES (2) | ES2683046T3 (pl) |
| HU (2) | HUE049728T2 (pl) |
| PL (2) | PL3345899T3 (pl) |
| PT (2) | PT3345899T (pl) |
| SI (1) | SI2820010T1 (pl) |
| WO (2) | WO2013130958A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3345899T3 (pl) * | 2012-03-01 | 2020-07-27 | Allergan, Inc. | Pochodne benzofurano-2-sulfonoamidu jako modulatory receptorów chemokin |
| ES2708563T3 (es) | 2013-03-12 | 2019-04-10 | Allergan Inc | Derivados de sulfonamida como moduladores de receptores de quimiocinas |
| WO2015084869A1 (en) * | 2013-12-02 | 2015-06-11 | Allergan, Inc. | Benzothiophene sulfonamides derivatives as chemokine receptor modulators |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1507756B1 (en) * | 2002-05-24 | 2015-07-22 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
| US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
| US20070021466A1 (en) * | 2002-11-18 | 2007-01-25 | Solomon Ungashe | CCR2 inhibitors and methods of use thereof |
| WO2005004810A2 (en) | 2003-07-02 | 2005-01-20 | Merck & Co., Inc. | Arylsulfonamide derivatives |
| WO2005016897A1 (en) * | 2003-08-08 | 2005-02-24 | Janssen Pharmaceutica, N.V. | Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| US7622583B2 (en) * | 2005-01-14 | 2009-11-24 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2 |
| US7931909B2 (en) | 2005-05-10 | 2011-04-26 | Allergan, Inc. | Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates |
| GB0524786D0 (en) | 2005-12-05 | 2006-01-11 | Glaxo Group Ltd | Compounds |
| US20100234364A1 (en) | 2006-07-14 | 2010-09-16 | Arindrajit Basak | Ccr2 inhibitors and methods of use thereof |
| US8519135B2 (en) | 2006-07-14 | 2013-08-27 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2/CCR9 |
| ATE498615T1 (de) | 2006-07-14 | 2011-03-15 | Chemocentryx Inc | Triazolylphenylbenzensulfonamide |
| WO2009009740A1 (en) | 2007-07-12 | 2009-01-15 | Chemocentryx, Inc. | Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treament of inflammation |
| TWI440638B (zh) | 2007-10-30 | 2014-06-11 | Otsuka Pharma Co Ltd | 雜環化合物及其藥學組成物 |
| AU2011344148B2 (en) * | 2010-12-16 | 2017-04-27 | Allergan, Inc. | Phosphorous derivatives as chemokine receptor modulators |
| CN108383828A (zh) * | 2010-12-16 | 2018-08-10 | 阿勒根公司 | 作为趋化因子受体调节剂的新的1，2-双-磺酰胺衍生物 |
| AU2012352572B2 (en) * | 2011-12-12 | 2017-08-17 | Allergan, Inc. | Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulators |
| PL3345899T3 (pl) * | 2012-03-01 | 2020-07-27 | Allergan, Inc. | Pochodne benzofurano-2-sulfonoamidu jako modulatory receptorów chemokin |
| ES2708563T3 (es) * | 2013-03-12 | 2019-04-10 | Allergan Inc | Derivados de sulfonamida como moduladores de receptores de quimiocinas |
-
2013
- 2013-03-01 PL PL18156011T patent/PL3345899T3/pl unknown
- 2013-03-01 HU HUE18156011A patent/HUE049728T2/hu unknown
- 2013-03-01 ES ES13711995.4T patent/ES2683046T3/es active Active
- 2013-03-01 EP EP18156011.1A patent/EP3345899B1/en active Active
- 2013-03-01 PL PL13711995T patent/PL2820010T3/pl unknown
- 2013-03-01 AU AU2013225815A patent/AU2013225815B2/en not_active Ceased
- 2013-03-01 PT PT181560111T patent/PT3345899T/pt unknown
- 2013-03-01 PT PT13711995T patent/PT2820010T/pt unknown
- 2013-03-01 DK DK18156011.1T patent/DK3345899T3/da active
- 2013-03-01 EP EP13711995.4A patent/EP2820010B1/en active Active
- 2013-03-01 DK DK13711995.4T patent/DK2820010T3/en active
- 2013-03-01 CA CA2866078A patent/CA2866078C/en active Active
- 2013-03-01 HU HUE13711995A patent/HUE038700T2/hu unknown
- 2013-03-01 US US13/782,174 patent/US8815915B2/en active Active
- 2013-03-01 US US13/782,159 patent/US8927544B2/en active Active
- 2013-03-01 WO PCT/US2013/028599 patent/WO2013130958A1/en not_active Ceased
- 2013-03-01 WO PCT/US2013/028607 patent/WO2013130962A1/en not_active Ceased
- 2013-03-01 SI SI201331119T patent/SI2820010T1/sl unknown
- 2013-03-01 ES ES18156011T patent/ES2791534T3/es active Active
-
2014
- 2014-07-17 US US14/334,145 patent/US9416120B2/en active Active
-
2015
- 2015-01-05 US US14/589,681 patent/US9550746B2/en active Active
-
2018
- 2018-01-11 AU AU2018200226A patent/AU2018200226B2/en not_active Ceased
- 2018-08-07 CY CY20181100816T patent/CY1120528T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE049728T2 (hu) | 2020-10-28 |
| US20130231339A1 (en) | 2013-09-05 |
| AU2013225815A1 (en) | 2014-09-25 |
| CY1120528T1 (el) | 2019-07-10 |
| DK3345899T3 (da) | 2020-05-11 |
| US8927544B2 (en) | 2015-01-06 |
| PT2820010T (pt) | 2018-10-01 |
| US9416120B2 (en) | 2016-08-16 |
| EP2820010A1 (en) | 2015-01-07 |
| ES2683046T3 (es) | 2018-09-24 |
| US20150218119A1 (en) | 2015-08-06 |
| SI2820010T1 (sl) | 2018-11-30 |
| US9550746B2 (en) | 2017-01-24 |
| HUE038700T2 (hu) | 2018-11-28 |
| EP3345899A1 (en) | 2018-07-11 |
| ES2791534T3 (es) | 2020-11-04 |
| EP3345899B1 (en) | 2020-02-19 |
| US20130231338A1 (en) | 2013-09-05 |
| WO2013130962A1 (en) | 2013-09-06 |
| AU2018200226A1 (en) | 2018-01-25 |
| WO2013130958A1 (en) | 2013-09-06 |
| PL3345899T3 (pl) | 2020-07-27 |
| US20140329813A1 (en) | 2014-11-06 |
| CA2866078C (en) | 2018-01-02 |
| US8815915B2 (en) | 2014-08-26 |
| DK2820010T3 (en) | 2018-08-06 |
| PT3345899T (pt) | 2020-05-20 |
| AU2013225815B2 (en) | 2017-10-12 |
| AU2018200226B2 (en) | 2019-09-19 |
| CA2866078A1 (en) | 2013-09-06 |
| EP2820010B1 (en) | 2018-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201213700D0 (en) | Receptor antagnists II | |
| IL237212A0 (en) | Amide derivatives of benzoimidazole carboxylic acid as apj receptor modulators | |
| EP2838881A4 (en) | ISO-INDOLONE DERIVATIVES | |
| IL236024A0 (en) | History of benzaimidazole-proline | |
| SI2844659T1 (sl) | Pirolotriazinonski derivati | |
| ZA201406390B (en) | Liver x receptor modulators | |
| AP2015008347A0 (en) | Oxazolidin-2-one-pyrimidine derivatives | |
| ZA201406326B (en) | Liver x receptor modulators | |
| ZA201500096B (en) | Indolecarbonitriles as selective androgen receptor modulators | |
| IL235557A0 (en) | Modulators of 17 gpr receptors | |
| IL239076A0 (en) | Novel and selective androgen receptor modulators | |
| GB201217285D0 (en) | Indole derivatives | |
| GB201223053D0 (en) | Receptor | |
| HUE038700T2 (hu) | Benzofuran-2-szulfonamid származékok, mint kemokinreceptor-modulációk | |
| AU2012904244A0 (en) | Neurotrophin-tyrosine kinase receptor signaling | |
| HUP1200360A2 (en) | Resolution by using n-acyl-phenylglycine derivatives |